Pharmacology: Blocking a gut reaction

    Article metrics

    Some metabolized cancer drugs are reactivated by bacteria in the gut as they pass through, causing severe diarrhoea. Matthew Redinbo at the University of North Carolina at Chapel Hill and his colleagues have identified the molecular structure of a key bacterial enzyme responsible, and have found several chemicals that prevent the reactivation.

    The small-molecule inhibitors block the active site of the enzyme, called β-glucuronidase, without killing the resident bacteria or harming mammalian cells, which produce a slightly different version of the enzyme. One inhibitor protected mice from diarrhoea and colon damage caused by the drug irinotecan. Similar treatment could allow cancer patients to tolerate higher, more effective doses of chemotherapy, the researchers say.

    Science 330, 831–835 (2010)

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Pharmacology: Blocking a gut reaction. Nature 468, 348 (2010) doi:10.1038/468348d

    Download citation


    By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.